{"id":22013,"date":"2012-04-11T14:25:56","date_gmt":"2012-04-11T18:25:56","guid":{"rendered":"http:\/\/1boringoldman.com\/?p=22013"},"modified":"2012-04-11T14:50:09","modified_gmt":"2012-04-11T18:50:09","slug":"and-11","status":"publish","type":"post","link":"https:\/\/1boringoldman.com\/index.php\/2012\/04\/11\/and-11\/","title":{"rendered":"and…"},"content":{"rendered":"
\n
\n
JNJ Told to Pay $1.1B in Arkansas Risperdal Trial<\/font><\/strong><\/u><\/a>
Bloomberg News<\/font><\/strong>
By Eric Francis and Jef Feeley
April 11, 2012<\/div>\n

<\/p>\n

JNJ  was ordered to pay more than $1.1 billion by a judge after an Arkansas jury found the company’s officials misled doctors and patients about the risks of the antipsychotic drug Risperdal. Judge Tim Fox in Little Rock, Arkansas, today found J&J and its Janssen unit committed more than 238,000 violations of the state’s Medicaid fraud laws by illegally marketing Risperdal over an almost four-year period starting in 2002. Fox found each violation carried a $5,000 fine, pushing the total to more than $1.1 billion.<\/p>\n

The penalty is the largest of the three handed down so far against New Brunswick, New Jersey-based J&J in state cases alleging the second-biggest (JNJ<\/a>)<\/span> maker of health products hid Risperdal’s risks and tricked Medicaid regulators into paying more than they should have for the medicine. “I think this ups the ante quite a bit on the other states’ cases targeting J&J’s Risperdal marketing,” Carl Tobias, who teaches product-liability law at the University Richmond law school, said in a telephone interview today. “I think the judge was sending a message – either settle these cases or litigate them at your peril.”<\/p>\n

A state jury concluded yesterday that J&J’s Risperdal marketing violated both Medicare fraud laws and Arkansas’s deceptive trade practices statutes. Fox ordered the drugmaker to pay $11.4 million in penalties on the trade practices violations.“We are disappointed with the judge’s decision on penalties,” Teresa Mueller, a spokeswoman for J&J’s Janssen unit, said in an e-mailed statement. “If our motion for a new trial is denied, we will appeal”…<\/sup><\/div>\n<\/blockquote>\n

\n
J&J Is Fined $1 Billion Over Risperdal Marketing<\/font><\/a> <\/strong><\/u>
Pharmalot<\/font><\/strong>
By Ed Silverman
April 11, 2012 <\/div>\n

<\/p>\n

… Overall, J&J has not fared well in defending its Risperdal efforts. Last year, the health care giant was ordered by a South Carolina judge to pay $327 million for deceptive Risperdal marketing, which he called detestable. And in 2010, a Louisiana jury ordered J&J to pay $257.7 million in damages for making misleading safety claims, and $73 million in legal fees were later added. <\/p>\n

In fact, the string of losses suggests J&J needs to pursue a settlement strategy. You may recall a deal with the feds unraveled after the health care giant balked at paying more than $1 billion. That deal had been reached prior to the recent settlement in Texas, however, prompting the feds to then seek a higher payout. <\/strong>Sources says the feds want J&J to pay anywhere from $1.3 billion to more than $1.8 billion and the Arkansas fine may embolden them to stand their ground.<\/p>\n

“Johnson & Johnson needs to wake up and realize they are playing a losing game. They should be running, not walking, to the settlement table,” Patrick Burns of Taxpayers Against Fraud, a non-profit, tells us. “DoJ offered a global settlement for $1.8 billion last month. I am not sure that deal is going to stay on the table after this”…<\/sup><\/div>\n<\/blockquote>\n

\n
<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

JNJ Told to Pay $1.1B in Arkansas Risperdal Trial Bloomberg News By Eric Francis and Jef Feeley April 11, 2012 JNJ  was ordered to pay more than $1.1 billion by a judge after an Arkansas jury found the company’s officials misled doctors and patients about the risks of the antipsychotic drug Risperdal. Judge Tim Fox […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-22013","post","type-post","status-publish","format-standard","hentry","category-politics"],"_links":{"self":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/22013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/comments?post=22013"}],"version-history":[{"count":6,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/22013\/revisions"}],"predecessor-version":[{"id":22019,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/22013\/revisions\/22019"}],"wp:attachment":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/media?parent=22013"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/categories?post=22013"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/tags?post=22013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}